Get started
Author

Sean D. MacKnight

Observed names: MacKnight, Sean D., S MacKnight, S. MacKnight, S. Macknight, S.D. MacKnight, Sean D MacKnight, Sean D. Macknight, Sean Dale MacKnight, Sean MacKnight, Sean Macknight
ORCID: 0000-0001-5032-2110
Observed ORCID: 0000-0001-5032-2110
OpenAlex ID: A5039497950
Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study
2022 · David Mannino, Michael Bogart, et al. · Respiratory Medicine · 61
PDF
Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking
2014 · Graeme W. Carlile, Renaud Robert, et al. · Journal of Cystic Fibrosis · 49
PDF
Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels
2020 · Alok A. Khorana, Nicole M. Kuderer, et al. · Cancer Medicine · 44
PDF
Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management
2022 · William W. Busse, Carl B. Abbott, et al. · The Journal of Allergy and Clinical Immunology In Practice · 34
PDF
Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation
2022 · David Mannino, Michael Bogart, et al. · International Journal of COPD · 28
PDF
Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States
2022 · Carlyne M. Averell, François Laliberté, et al. · Therapeutic Advances in Respiratory Disease · 20
Real-world mepolizumab treatment in eosinophilic granulomatosis with polyangiitis reduces disease burden in the United States
2024 · Sameer K. Mathur, Jared Silver, et al. · Annals of Allergy Asthma & Immunology · 16
Real-world Adherence to Single-inhaler Vs Multiple-inhaler Triple Therapy Among Patients With Copd in a Commercially Insured Us Population
2020 · Michael Bogart, Benjamin Wu, et al. · CHEST Journal · 13
PDF
The real-world health resource use and costs of misdiagnosing bipolar I disorder
2022 · Roger S. McIntyre, François Laliberté, et al. · Journal of Affective Disorders · 11
PDF
Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma
2024 · Thomas B Casale, Thomas Corbridge, et al. · Allergy Asthma and Clinical Immunology · 9
PDF
Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease
2021 · David Slade, Riju Ray, et al. · Pulmonary Therapy · 8
PDF
Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities
2021 · Ravi Kalhan, David Slade, et al. · International Journal of COPD · 7
PDF
Impact of formulary-related pharmacy claim rejections of cariprazine on health care utilization and treatment patterns among patients with bipolar I disorder
2024 · François Laliberté, Enrico Zanardo, et al. · Journal of Managed Care & Specialty Pharmacy · 6
PDF
Impact of cariprazine on body weight and blood pressure among adults with bipolar I disorder, schizophrenia, or major depressive disorder in a real-world setting
2025 · Christoph U. Correll, Andrew J. Cutler, et al. · Annals of General Psychiatry · 5
PDF
Pre-Exposure Prophylaxis for the Prevention of HIV-1: An Assessment of Oral Pre-Exposure Prophylaxis Usage Patterns, First Evidence of HIV-1, and HIV-1 Risk Factors in the United States
2024 · Alan Oglesby, Guillaume Germain, et al. · AIDS Patient Care and STDs · 5
PDF
Healthcare costs of NVAF patients treated with rivaroxaban and apixaban in the US
2020 · Dejan Milentijevic, Guillaume Germain, et al. · Journal of Medical Economics · 5
PDF
Healthcare costs of patients with cancer stratified by Khorana score risk levels
2021 · Alok A. Khorana, Nicole M. Kuderer, et al. · Journal of Medical Economics · 4
Healthcare resource utilization and costs associated with first versus subsequent use of cariprazine for bipolar I disorder
2024 · Andrew J. Cutler, François Laliberté, et al. · Journal of Medical Economics · 3
Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count
2024 · Guillaume Germain, Karen Worley, et al. · Lupus Science & Medicine · 3
PDF
Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA
2020 · François Laliberté, Monika Raut, et al. · Targeted Oncology · 3
PDF
Real-World Assessment of All-Cause Hospital Readmissions among Pulmonary Embolism Patients Treated With Rivaroxaban Versus Apixaban
2025 · Veronica Ashton, Guillaume Germain, et al. · Clinical and Applied Thrombosis/Hemostasis · 2
853. Real-World Persistency of Patients Receiving Tenofovir-Based Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the US
2021 · Alan Oglesby, Guillaume Germain, et al. · Open Forum Infectious Diseases · 2
REAL‐WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) OF CLASSICAL HODGKIN LYMPHOMA (cHL) PATIENTS (PTS) TREATED WITH ANTI‐PD1 CHECKPOINT INHIBITORS IN THE UNITED STATES (US)
2019 · F. Laliberté, M. Raut, et al. · Hematological Oncology · 2
Effectiveness of Leniolisib in Reducing Infections Among Patients With Activated Phosphoinositide 3-kinase Delta Syndrome (apds)
2025 · N. Patel, J. Kuivinen, et al. · Annals of Allergy Asthma & Immunology · 1
PDF
Reductions in medical visits and hospitalizations following berotralstat initiation in patients with hereditary angioedema in the United States
2025 · Sandra C. Christiansen, Lorena Lopez-Gonzalez, et al. · Journal of Managed Care & Specialty Pharmacy · 1
Works count: 59
Citation count: 344
H-index: 9
I10-index: 9
Year
Topic
Type